Developmental funds have played a key role in facilitating scientific growth and increased interdisciplinary collaboration at Virginia Commonwealth University (VCU) Massey Cancer Center (MCC) during the current funding period. Over the current funding cycle, $80,899 per year was awarded and expended on one new faculty recruitment, one pilot project per year, and support of the development of a Behavioral Measurement Shared Resource (BeMSR), which is being put forth as a competing shared resource as part of this renewal application. We are requesting $295,000 per year of CCSG support for our development program to recruit six new investigators over five years as part of planned expansions of Center programs, to fund up to three pilot projects per year, and to support the development of three new shared resource facilities. The faculty recruit supported by CCSG funds during the current funding period has already received support from NCI. MCC and institutional resources also provided support in the recruitment of 23 additional faculty members to VCU and MCC. Of these, eight have received new NCI funding (35%) with $6.8 M (direct costs, all years) and an additional $6.5 M (total direct costs, all years) in NIH and other extramural funding. Faculty positions and space for recruitment priorities for the next five years have been Identified. While the requested CCSG funds will be more than matched with MCC and institutional funds to accomplish these planned recruitments, pilot projects, and shared cores, the CCSG funds provide critical leverage to obtain matching funds from other institutional sources. Our pilot research project program received a total of 26 applications for the two most recent rounds of funding in 2010. Of these, 13 (50%) were awarded. Over the current funding period, a total of 63 applications were received for review, with a total of 27 (43%) approved for funding with 28.6% awarded in 2008-2009 resulting in extramural funding. The requested increase in CCSG funding will allow us to fund more of these key applications. Member surveys and Program discussions identified specific scientific member needs in the areas of lipidomics, high throughput sequencing, and imaging services. Once the need for each resource was agreed upon and endorsed by Dr Ginder, the identification of space, the acquisition of equipment, and the identification of potential directors was undertaken. Institutional commitment has also been secured to include the personnel required to launch the proposed activities.

Public Health Relevance

Developmental funds provided through the Cancer Center Support Grant insure essential resources are available to VCU Massey Cancer Center researchers to aid in programmatic development and scientific growth. These funds provide a basis to build interdisciplinary collaborations and foster new discoveries in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-32
Application #
8559588
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
32
Fiscal Year
2013
Total Cost
$143,564
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Nulton, Tara J; Kim, Nak-Kyeong; DiNardo, Laurence J et al. (2018) Patients with integrated HPV16 in head and neck cancer show poor survival. Oral Oncol 80:52-55
Porter-Stransky, Kirsten A; Centanni, Samuel W; Karne, Saumya L et al. (2018) Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal. Biol Psychiatry :
Cobb, Caroline O; Soule, Eric K; Rudy, Alyssa K et al. (2018) Patterns and Correlates of Tobacco and Cannabis co-use by Tobacco Product Type: Findings from the Virginia Youth Survey. Subst Use Misuse 53:2310-2319
Sonnenschein, Halie A; Lawrence, Kenneth F; Wittenberg, Karli A et al. (2018) Suppressor of IKKepsilon forms direct interactions with cytoskeletal proteins, tubulin and ?-actinin, linking innate immunity to the cytoskeleton. FEBS Open Bio 8:1064-1082
Curry, Zachary A; Wilkerson, Jenny L; Bagdas, Deniz et al. (2018) Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy. J Pharmacol Exp Ther 366:169-183
Radwa?ska, Malwina J; Jaskó?owski, Mateusz; Davydova, Elena et al. (2018) The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab. Acta Crystallogr D Struct Biol 74:681-689
Lancina 3rd, Michael G; Wang, Juan; Williamson, Geoffrey S et al. (2018) DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment. Mol Pharm 15:2883-2889
Ginder, Gordon D; Williams Jr, David C (2018) Readers of DNA methylation, the MBD family as potential therapeutic targets. Pharmacol Ther 184:98-111
Chernoukhov, A; Hussein, A; Nkurunziza, S et al. (2018) Bayesian inference in time-varying additive hazards models with applications to disease mapping. Environmetrics 29:
Karandashova, Sophia; Kummarapurugu, Apparao B; Zheng, Shuo et al. (2018) Neutrophil elastase increases airway ceramide levels via upregulation of serine palmitoyltransferase. Am J Physiol Lung Cell Mol Physiol 314:L206-L214

Showing the most recent 10 out of 586 publications